These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11297265)

  • 1. Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor.
    Lammering G; Valerie K; Lin PS; Mikkelsen RB; Contessa JN; Feden JP; Farnsworth J; Dent P; Schmidt-Ullrich RK
    Clin Cancer Res; 2001 Mar; 7(3):682-90. PubMed ID: 11297265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity.
    Lammering G; Hewit TH; Holmes M; Valerie K; Hawkins W; Lin PS; Mikkelsen RB; Schmidt-Ullrich RK
    Clin Cancer Res; 2004 Oct; 10(19):6732-43. PubMed ID: 15475464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inducible expression of dominant-negative epidermal growth factor receptor-CD533 results in radiosensitization of human mammary carcinoma cells.
    Contessa JN; Reardon DB; Todd D; Dent P; Mikkelsen RB; Valerie K; Bowers GD; Schmidt-Ullrich RK
    Clin Cancer Res; 1999 Feb; 5(2):405-11. PubMed ID: 10037190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated overexpression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells.
    Lammering G; Lin PS; Contessa JN; Hampton JL; Valerie K; Schmidt-Ullrich RK
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):775-84. PubMed ID: 11697324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ErbB receptor tyrosine kinase network inhibition radiosensitizes carcinoma cells.
    Contessa JN; Abell A; Valerie K; Lin PS; Schmidt-Ullrich RK
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):851-8. PubMed ID: 16751066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization.
    Lammering G; Hewit TH; Hawkins WT; Contessa JN; Reardon DB; Lin PS; Valerie K; Dent P; Mikkelsen RB; Schmidt-Ullrich RK
    J Natl Cancer Inst; 2001 Jun; 93(12):921-9. PubMed ID: 11416113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation-induced activation of a common variant of EGFR confers enhanced radioresistance.
    Lammering G; Valerie K; Lin PS; Hewit TH; Schmidt-Ullrich RK
    Radiother Oncol; 2004 Sep; 72(3):267-73. PubMed ID: 15450724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFr) enhances the radiosensitization properties of anti-EGFr treatment in prostate cancer cells.
    Bonner JA; Buchsbaum DJ; Rogers BE; Grizzle WE; Trummell HQ; Curiel DT; Fiveash JB; Ove R; Raisch KP
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):950-8. PubMed ID: 14967455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiosensitization of Ras-mutated human tumor cells in vitro by the specific EGF receptor antagonist BIBX1382BS.
    Toulany M; Dittmann K; Baumann M; Rodemann HP
    Radiother Oncol; 2005 Feb; 74(2):117-29. PubMed ID: 15734199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
    Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
    Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protracted exposure radiosensitization of experimental human malignant glioma.
    Williams JA; Williams JR; Yuan X; Dillehay LE
    Radiat Oncol Investig; 1998; 6(6):255-63. PubMed ID: 9885941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells.
    Reardon DB; Contessa JN; Mikkelsen RB; Valerie K; Amir C; Dent P; Schmidt-Ullrich RK
    Oncogene; 1999 Aug; 18(33):4756-66. PubMed ID: 10467423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAb 806 enhances the efficacy of ionizing radiation in glioma xenografts expressing the de2-7 epidermal growth factor receptor.
    Johns TG; McKay MJ; Cvrljevic AN; Gan HK; Taylor C; Xu H; Smyth FE; Scott AM
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):572-8. PubMed ID: 20638193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
    Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
    J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.
    Contessa JN; Abell A; Mikkelsen RB; Valerie K; Schmidt-Ullrich RK
    Breast Cancer Res Treat; 2006 Jan; 95(1):17-27. PubMed ID: 16267617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
    Kaliberov S; Stackhouse MA; Kaliberova L; Zhou T; Buchsbaum DJ
    Gene Ther; 2004 Apr; 11(8):658-67. PubMed ID: 14973547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft.
    Staba MJ; Mauceri HJ; Kufe DW; Hallahan DE; Weichselbaum RR
    Gene Ther; 1998 Mar; 5(3):293-300. PubMed ID: 9614548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological inhibition of EGFR tyrosine kinase affects ILK-mediated cellular radiosensitization in vitro.
    Eke I; Sandfort V; Storch K; Baumann M; Röper B; Cordes N
    Int J Radiat Biol; 2007; 83(11-12):793-802. PubMed ID: 18058367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionizing radiation causes a dose-dependent release of transforming growth factor alpha in vitro from irradiated xenografts and during palliative treatment of hormone-refractory prostate carcinoma.
    Hagan M; Yacoub A; Dent P
    Clin Cancer Res; 2004 Sep; 10(17):5724-31. PubMed ID: 15355899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substantially improved in vivo radiosensitization of rat glioma with mutant HSV-TK and acyclovir.
    Valerie K; Hawkins W; Farnsworth J; Schmidt-Ullrich R; Lin PS; Amir C; Feden J
    Cancer Gene Ther; 2001 Jan; 8(1):3-8. PubMed ID: 11219491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.